The Breast Cancer Update hits the screens!

We are pleased to present the Breast Cancer Update EVENT on the JFIM website. The LIVE zone will be open on Monday March 21st at 09:00 (UTC +4).
You will find the navigation pad on the JFIM homepage. Access to the LIVE SESSION and REPLAY areas are reserved to the BCU registered attendees.
Registration remains open in the REGISTRATION tab.
To access the content, use the LOGIN button at the top right of the JFIM banner

Breast Cancer Update

DUBAI 2022 March 21-23


The Breast Cancer Update hits the screens!

The live broadcasting will take place in the LIVE SESSION area

A QR CODE will be present in the page. This will allow you to ask questions live to the moderators using your cell phone. A link will also be available if you are on your computer.
The sessions are in English.
The REPLAY of the sessions will start on the first day

The videos will be indexed with navigation features for computers (Microsoft, IOS, Android) tablets and mobiles (except iphone and ipad / videos and slides available without navigation).
The REPLAY zone will remain open for 2 months after the congress.

If you want to change your settings / password. Switch to a computer or a tablet and access the settings tab at the top right of the screen.

SYMPOSIUM replays.

This area will be open to JFIM subscribers who are not registered to the congress

Delegates present in Dubai have online access and will be able to ask their questions via their smartphone.

BCU a conference with innovative formats

• The format of the speeches will be deliberately short, 10 minutes per speaker
• A program and discussions based on multidisciplinary team meetings model
• LIVE SESSION on the JFIM websites with same-day replays
• Communication language will be English.

The BCU is a conference for all breast cancer specialists

In 2020/21, 2.3 million women were diagnosed with breast cancer and over the last 5 years, 7.8 million women have been diagnosed with this disease, making it the most common cancer in the world. Over the past 40 years, advances in treatment have doubled patient survival and it is estimated that today 85% of women survive 5 years or more after a breast cancer diagnosis. Progress continues and solutions are emerging even in particularly difficult cases such as triple negative breast cancer with antibody drugs conjugates and chemotherapy.

Together, let's continue to move forward.

Have a good conference.

Dr Luc Rotenberg Secrétaire General du BCU
Dr Jean-Philippe MINART Rédacteur en Chef de

Our latest ressources